U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H23NO
Molecular Weight 233.3498
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-(2-METHOXYETHYL)-1-PHENYLCYCLOHEXANAMINE

SMILES

COCCNC1(CCCCC1)c2ccccc2

InChI

InChIKey=MSZKHYPXVOHFEV-UHFFFAOYSA-N
InChI=1S/C15H23NO/c1-17-13-12-16-15(10-6-3-7-11-15)14-8-4-2-5-9-14/h2,4-5,8-9,16H,3,6-7,10-13H2,1H3

HIDE SMILES / InChI

Molecular Formula C15H23NO
Molecular Weight 233.3498
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Jun 26 07:53:33 UTC 2021
Edited
by admin
on Sat Jun 26 07:53:33 UTC 2021
Record UNII
7I739G61XS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-(2-METHOXYETHYL)-1-PHENYLCYCLOHEXANAMINE
Systematic Name English
PCMEA
Common Name English
N-(1-PHENYLCYCLOHEXYL)-2-METHOXYETHANAMINE
Systematic Name English
CYCLOHEXANAMINE, N-(2-METHOXYETHYL)-1-PHENYL-
Systematic Name English
Code System Code Type Description
FDA UNII
7I739G61XS
Created by admin on Sat Jun 26 07:53:33 UTC 2021 , Edited by admin on Sat Jun 26 07:53:33 UTC 2021
PRIMARY
CAS
2201-57-2
Created by admin on Sat Jun 26 07:53:33 UTC 2021 , Edited by admin on Sat Jun 26 07:53:33 UTC 2021
PRIMARY
PUBCHEM
46839344
Created by admin on Sat Jun 26 07:53:33 UTC 2021 , Edited by admin on Sat Jun 26 07:53:33 UTC 2021
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> INDUCER
MAJOR
Related Record Type Details
METABOLITE -> PARENT
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
METABOLITE -> PARENT
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
METABOLITE -> PARENT
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE